wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47299048-3779C9DF-BFF9-4436-A3A4-A06454CD06B9
Q47299048-3779C9DF-BFF9-4436-A3A4-A06454CD06B9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47299048-3779C9DF-BFF9-4436-A3A4-A06454CD06B9
Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
P2860
Q47299048-3779C9DF-BFF9-4436-A3A4-A06454CD06B9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47299048-3779C9DF-BFF9-4436-A3A4-A06454CD06B9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1fad1ee2a0772501118edc2d45c8577430fa31de
P2860
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.